Biejiajian Pill Promotes the Infiltration of CD8+ T Cells in Hepatocellular Carcinoma by Regulating the Expression of CCL5

• मुख्य लेखकों: Xuemei Yang (लेखक), Jialing Sun (लेखक), Bin Wen (लेखक), Yu Wang (लेखक), Mingjia Zhang (लेखक), Weicong Chen (लेखक), Wenting Zhao (लेखक), Chunyu He (लेखक), Xiaodan Zhong (लेखक), Yang Liu (लेखक), Tong Li (लेखक), Haitao Sun (लेखक), Songqi He (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Frontiers Media S.A., 2021-11-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Tumor-infiltrating CD8+T lymphocytes are mostly associated with a favorable prognosis in numerous cancers, including hepatocellular carcinoma (HCC). Biejiajian Pill (BJJP) is a common type of traditional Chinese medicine that is widely used in the treatment of HCC in China. Previous studies showed t...